Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Virpax Pharmaceuticals Inc VRPX

Healthcare
Virpax Pharmaceuticals, Inc. is a preclinical-stage pharmaceutical company. The Company is focused on developing novel and proprietary drug delivery systems across various pain indication. Its drug-delivery systems and drug-releasing technologies being developed are focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system (CNS... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:VRPX)

Virpax Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic Non-Cancer Pain Alternative

Business Wire 12 hours ago

Virpax Pharmaceuticals, Inc. Announces Closing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants

Business Wire 6 days ago

Virpax Pharmaceuticals, Inc. Announces Pricing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants

Business Wire 8 days ago

Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer

GlobeNewswire November 5, 2024

Virpax Pharmaceuticals Reports 2024 Second Quarter Results and Recent Developments

Business Wire August 13, 2024

Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference August 14-15

Business Wire August 8, 2024

Virpax Regains Compliance with Nasdaq Minimum Bid Price

Business Wire July 24, 2024

Virpax Announces Positive Results of Swine Model Pilot Study for Probudur(TM)

Business Wire July 10, 2024

Virpax Pharmaceuticals Secures $2.5 Million Loan Financing and an Agreement with an Institutional Investor to Negotiate Additional Funding

Business Wire July 8, 2024
View More News ››

Opinion & Analysis (NDAQ:VRPX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:VRPX)

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX): Navigating the C

http://beyondspx.com/2024/08/02/virpax-pharmaceuticals-inc-nasdaqvrpx-navigating-the-challenges-of-a-preclinical-stage-pharmaceutical...
MikeTester - August 3, 2024

Spotting Penny Stocks With Breakout Potential, 3 Tips

NEWS: $VRPX Spotting Penny Stocks With Breakout Potential, 3 Tips2024-07-09 06:01:00 ET 3 Tips for Spotting Penny Stocks That Could...
whytestocks - July 9, 2024

Why Arhaus Shares Are Trading Lower By Around 8%? Here Are O

Breaking News: $VRPX Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session...
whytestocks - July 8, 2024

Virpax Pharmaceuticals Announces Reverse Stock Split to Rega

Just In: $VRPX Virpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid PriceVirpax &...
whytestocks - February 27, 2024

Buy buy buy

Looking fine after market buy at .27
Nibinator - December 14, 2023

📢📢📣📣📺FSD Pharma Inc CEO Anthony Durkacz (Nasdaq: HUGE)

<< View Post To Watch Video >>
LinethRamirez - August 23, 2021
View more Bullboard ››

Bank of Montreal

Bank of Montreal

Bank of Montreal (BMO) is a Canada-based company, which offers a wide range of personal banking services. The Company is ...
View More »